A detailed history of Cwa Asset Management Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 87,192 shares of BMY stock, worth $5.03 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
87,192
Previous 117,538 25.82%
Holding current value
$5.03 Million
Previous $6.37 Million 29.21%
% of portfolio
0.24%
Previous 0.39%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $1.2 Million - $1.57 Million
-30,346 Reduced 25.82%
87,192 $4.51 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $4.42 Million - $5.01 Million
92,099 Added 362.04%
117,538 $6.37 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $840,255 - $1 Million
17,332 Added 213.79%
25,439 $1.31 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $16,382 - $18,318
283 Added 3.62%
8,107 $470,000
Q2 2023

Jul 27, 2023

BUY
$63.71 - $70.74 $94,609 - $105,048
1,485 Added 23.43%
7,824 $500,000
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $227,947 - $258,544
-3,469 Reduced 35.37%
6,339 $439,000
Q4 2022

Jan 09, 2023

SELL
$68.48 - $81.09 $16,777 - $19,867
-245 Reduced 2.44%
9,808 $0
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $18 - $10,757
140 Added 1.41%
10,053 $715,000
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $944 - $1,039
-13 Reduced 0.13%
9,913 $763,000
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $226,492 - $271,584
3,684 Added 59.02%
9,926 $725,000
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $39,042 - $45,514
-728 Reduced 10.44%
6,242 $389,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $36,626 - $42,902
619 Added 9.75%
6,970 $412,000
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $41,417 - $45,103
-669 Reduced 9.53%
6,351 $423,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $296 - $333
5 Added 0.07%
7,020 $443,000
Q4 2020

Feb 23, 2021

BUY
$57.74 - $65.43 $115 - $130
2 Added 0.03%
7,015 $435,000
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $26,329 - $29,836
-456 Reduced 6.11%
7,013 $435,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $49,906 - $55,303
-869 Reduced 10.42%
7,469 $450,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $53,339 - $62,359
-973 Reduced 10.45%
8,338 $490,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $62,779 - $91,232
-1,353 Reduced 12.69%
9,311 $519,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $524,775 - $684,522
10,664 New
10,664 $685,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.